- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05146167
Testing a Meditation App With Justice-Involved Youth on Probation (Project AIM)
January 9, 2023 updated by: Ashley D Kendall, University of Illinois at Chicago
Reducing HIV/Sexually Transmitted Infection (STI) Risk Behaviors Among Juvenile Offenders on Probation: A Mobile Mindfulness-Based Intervention
This study is a randomized controlled trial (RCT) testing the effects of a mindfulness-based intervention delivered to justice-involved youth on probation via smartphone app on youths' emotion regulation and HIV/sexually transmitted infection (STI) risk-taking behaviors (i.e., alcohol use, cannabis use, sexual behaviors, and aggressive behaviors).
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
The investigators will enroll 200 justice-involved youth on probation 13-18 years old of all genders who report regular access to an Apple or Android smartphone.
Following completion of a baseline questionnaire, participants will be individually randomized at a 1:1 ratio to 1 of 2 smartphone app conditions: (1) Bodhi AIM (Action In Mindfulness), a 30-day mindfulness-based intervention, or (2) HIB (Health In Balance), a health promotion control app matched to Bodhi AIM for time and structure.
Follow-up assessments will occur at 1 and 6 months.
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ashley D Kendall, PhD
- Phone Number: (312) 355-1836
- Email: akendall@uic.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Recruiting
- University of Illinois at Chicago
-
Contact:
- Ashley D Kendall, PhD
- Phone Number: 312-355-1836
- Email: akendall@uic.edu
-
Principal Investigator:
- Ashley D Kendall, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 13-18 years old
- On probation in the Chicago Cook County Juvenile Justice System
Exclusion Criteria:
- Unable to understand the permission/consent/assent process
- Do not speak English, due to norming of instruments
- Do not assent/consent
- Legal guardian does not give permission for youth's participation if under 18 years old
- Do not have an Apple or Android phone
- Are detained
- Are in care of DCFS
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bodhi AIM
Participants randomized to the intervention group will receive the Bodhi AIM app
|
Bodhi AIM (Action In Mindfulness) is a smartphone-based app that teaches users to establish a daily meditation practice via a 30-day "path," with each day consisting of a brief audio- or video-guided file.
In addition to the 30 daily path files, users have access to a menu of "to go" audio-guided meditation practices that they may access any time to prepare for particular situations (e.g., attending a party).
|
Active Comparator: HIB
Participants randomized to the health promotion control group will receive the HIB app
|
HIB (Health In Balance) is a smartphone-based app that is matched to Bodhi AIM for time and structure, but includes health promotion content (e.g., educational information on substance use) in place of the meditation content featured in Bodhi AIM.
Like Bodhi AIM, HIB includes a 30-day "path" of audio and video files, along with a menu of "to go" audio files that users may access any time to review key intervention concepts.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Negative Emotion Regulation
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Negative Emotion Regulation as measured by the Negative Mood Regulation Scale [At baseline, 1-month follow-up, and 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Alcohol Use
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Alcohol Use as measured by the Young Adult Alcohol Problem Scale [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Cannabis Use
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Cannabis Use as measured by the Cannabis Use Disorders Identification Test - Revised [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Sexual Behavior
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Sexual Behavior as measured by a modified version of the AIDS Risk Behavior Assessment [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Aggression
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Aggression as measured by the Reactive-Proactive Aggression Questionnaire [At baseline, 1-month follow-up, and 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Positive Emotion Regulation
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Positive Emotion Regulation as measured by the Connor-Davidson Resilience Scale 10 [1-month time period at baseline, 1-month follow-up, and 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Mindfulness
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Mindfulness as measured by the Five Facets of Mindfulness Questionnaire [At baseline, 1-month follow-up, and 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Alcohol Trouble
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Alcohol Trouble as measured by the Alcohol Trouble Scale [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Hangover Symptoms
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Hangover Symptoms as measured by the Hangover Symptoms Scale [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Substance Use Attitudes and Beliefs
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Substance Use Attitudes and Beliefs as measured by a modified version of the Alcohol Abstinence Self-Efficacy Scale [At baseline, 1-month follow-up, and 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Additional Facets of Aggression
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Additional Facets of Aggression as measured by the Short-Form Buss-Perry Aggression Questionnaire [At baseline, 1-month follow-up, and 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Mental Health Symptoms
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Mental Health Symptoms as measured by the Youth Self-Report (YSR) [6-month time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Trauma Symptoms
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Changes in Trauma Symptoms as measured by the UCLA PTSD Rating Index [1-month time period at baseline, 1-month follow-up, and 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
App Usage
Time Frame: Up through 6-month follow-up
|
App Usage as assessed by objective app usage data (date/time stamps for each app feature) [Up through 6-month follow-up]
|
Up through 6-month follow-up
|
Digital Working Alliance
Time Frame: 1-month follow-up
|
Digital Working Alliance as measured by the Digital Working Alliance Inventory [At 1-month follow-up]
|
1-month follow-up
|
Juvenile Justice Involvement
Time Frame: Baseline, 1-month follow-up, 6-month follow-up
|
Juvenile Justice Involvement (i.e., number of arrests, charge(s), number of detainments) [Lifetime time period at baseline, 1-month time period at 1-month follow-up, 6-month time period at 6-month follow-up]
|
Baseline, 1-month follow-up, 6-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Ashley D Kendall, PhD, University of Illinois at Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 5, 2022
Primary Completion (Anticipated)
February 28, 2024
Study Completion (Anticipated)
February 28, 2024
Study Registration Dates
First Submitted
November 8, 2021
First Submitted That Met QC Criteria
November 23, 2021
First Posted (Actual)
December 6, 2021
Study Record Updates
Last Update Posted (Estimate)
January 11, 2023
Last Update Submitted That Met QC Criteria
January 9, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-0889
- R00DA047890 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
De-identified data may be placed in one or more electronic databases which could be used for other research studies.
IPD Sharing Time Frame
Data sharing will generally coincide with publication of the study's main findings and is intended to take place within 1 year after acceptance of the primary manuscripts.
IPD Sharing Access Criteria
To be determined
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aggression
-
University of KonstanzCompletedAppetitive AggressionGermany
-
New York State Psychiatric InstituteCompletedIrritable AggressionUnited States
-
Boston UniversityU.S. Department of JusticeCompletedSexual Aggression | Offensive Aggression | Dating Violence Perpetration and VictimizationUnited States
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive AggressionUnited States
-
Weill Medical College of Cornell UniversityGreen Chimneys Residential Treatment Center, Brewster, NYCompletedChildhood AggressionUnited States
-
University of WashingtonNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Arizona State UniversityCompletedHeavy Drinking | Sexual AggressionUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive Aggression Comorbid With ADHDUnited Kingdom
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityNot yet recruitingAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
-
Arizona State UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Georgia State UniversityCompletedAlcohol Drinking | Sexual Behavior | Emotions | Sexual AggressionUnited States
Clinical Trials on Bodhi AIM (intervention group)
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); United States Department of Defense; National...RecruitingLung Cancer | Cancer of ThoraxUnited States
-
University of FloridaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
Dartmouth-Hitchcock Medical CenterRecruiting
-
Washington University School of MedicineRecruitingAbdominal Aortic Aneurysm (AAA) | No Abdominal Aortic Aneurysm (Non-AAA)United States
-
Northwestern UniversityWithdrawnIndividuals at Risk for DepressionUnited States
-
Terry L. WahlsRecruitingMultiple Sclerosis | Clinically Isolated Syndrome | Fibromyalgia | Post Acute Sequelae of COVID-19United States
-
Wake Forest University Health SciencesCompletedHead Injury | Sport InjuryUnited States
-
Queen Mary University of LondonGuy's and St Thomas' NHS Foundation Trust; Barts & The London NHS Trust; Royal... and other collaboratorsActive, not recruitingHuman Immunodeficiency VirusesUnited Kingdom
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...RecruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium